It’s not just men that find more hair in their brushes than on their heads though. As it turns out, women are just as susceptible to hair loss with 40% suffering from visible hair loss by the age of 40. For both men and women though, a new light of hope is shining down with the potential to help regrow that lost hair and regain confidence once again through low level laser therapy.
What is Low Level Laser Therapy?
Low level laser therapy, or LLLT for short, was created in Central Europe as a non-surgical method for restoring hair growth. By using infrared light therapy on the scalp, it stimulates hair follicles to start hair growing once again. LLLT is different than other cosmetic lasers since it doesn’t use any thermal components. Instead of dealing with messy creams or painful surgical procedures, low level laser therapy is restoring both hair and hope for men and women with hair loss.
How Does LLLT Work?
LLLT is considered a therapeutic exposure to red or near-infrared radiation. This light energy is delivered precisely into your scalp which then gets the cells working again while boosting blood circulation. With that improved circulation, more oxygen is delivered to the hair follicles to stimulate the growth of new hair.
Nearly 70% of the hairs are coaxed from the resting phase back into the growing phase using this effective method of wavelengths. It’s fascinating as on the other end of the spectrum, other wavelengths can harm you, though low laser therapy is very safe. To undergo low level laser therapy, you can receive treatment at a doctor’s office for 20 to 60 minutes per session.
Do Lasers Really Regrow Hair?
When laser technology first came out in 1960, they began exploring its potential to aid in human health. While some were harmful, they found that certain wavelengths as are now used in LLLT could be beneficial to restoring hair growth. Depending on the wavelength, pulse rate, ad length and frequency of exposure, these lasers can encourage hair growth. Research in both mice and humans was critical in bringing LLLT into doctor’s offices and into homes via personal laser devices designed to regrow hair.
What are the Benefits of Laser Hair Restoration?
If you’d like to restore your hairline and regain confidence, low level laser therapy might be for you. It’s non-surgical and painless so you won’t dread your appointments with your doctor or be afraid to use it in your own home. There won’t be any telltale scars left behind either to give you away.
LLLT ends the hair loss cycle while stimulating those dormant hair follicles. This allows hair to grow where it has thinned out or even left bald patches. Both the hair that you currently have and the new hair become stronger, thicker, and fuller. Sessions take up very little time, plus there’s no downtime afterward. You can go about your day as you would any other.
What are the Expected Hair Regrowth Stages and Results Timeline?
If you’re bothered by your hair loss, consider low level laser therapy to help restore your hair growth. Thanks to the increase of oxygen and boost in circulation, further hair loss is halted and even dormant follicles will begin to grow hair once again.
Studies show encouraging results with 39% hair growth in about 16 weeks. On average, you can expect a session to last 30 minutes. It’s a relaxing treatment though it will take multiple sessions to see the best results. Some will see results more rapidly, around 12 weeks from the start of LLLT treatments while for others, it could take up to 6 months.
Is it too Soon to Start LLLT Sessions if My Hair is Just Starting to Thin Out?
Not at all! In fact, the best time to start LLLT treatments is in the early stages of hair loss. If your hair is not growing as long or as thick and dense as it did when you were young, you should consider trying it. Even if you’ve tried other types of hair growth therapies like minoxidil, LLLT can help stimulate new hair growth and change your outlook.
Does LLLT Hurt?
As it is non-surgical and non-invasive, low level laser therapy doesn’t hurt at all. In fact, it’s a very relaxing procedure that allows you to recline and let the lasers do all the work. You won’t feel anything except a sensation of calm and peace while the treatment is going on.
What are the Side Effects?
LLLT has been researched for quite some time and is clinically-proven to be both safe and effective for hair growth. While most people in the beginning stages of hair loss will benefit from it, you should talk to your doctor if you’re taking any medications for other conditions. Certain medications can interact with LLLT, particularly those that are photosensitizing.
Am I an Ideal Candidate?
Both men and women with beginning stages of hair loss are ideal candidates for low level laser therapy. Even if you’ve had recently grafted hair, you can have LLLT to speed up its growth. If you’re self-conscious about your thinning hair, you should try it.
What are the Differences Between In-Office Treatments vs. Home Devices?
When you go to us for LLLT treatment including follow-up appointments, you will experience better hair growth. At home though, it depends on the device you purchase. There are many cheap versions that don’t use the right kind of wavelengths of light to cut costs. That means they won’t work for you. Some don’t have enough laser points to target the whole scalp while others don’t have proper calibration for boosting hair growth. In the case of LLLT hair combs, they are more trouble than they’re worth. If you want to use an at-home device, you should look for something that is quality-rated to ensure it can boost your hair growth.
Should I Use LLLT with Other Medical Therapies or Procedures or Can It Work on its Own?
Depending on your gender and situation, you may find other treatment results are boosted with the use of LLLT. You can even use it if you’ve had surgical treatments for replacing hair, use creams, or have used PRP (platelet rich plasma) treatments.
Ultimately, if you’re wondering if you could benefit from LLLT, it’s worth making an appointment to discuss about it so you can finally restore your self-confidence along with your hair!
Male androgenetic alopecia (AGA) is the most frequent type of thinning or loss of hair in males. The condition, also known as male pattern baldness, causes hair loss as early as late adolescence. Polygenic heredity is assumed to be the primary cause, although the male hormone testosterone plays an important role, seemingly independent of genetic predisposition. In the hair follicle cells, testosterone is converted into the biologically more active metabolite, 5α-dihydrotestosterone (DHT) catalyzed by the enzyme 5-alpha reductase. This hormone binds to androgenic receptors in the hair follicle and the specific bond triggers cellular processes, which reduce the anagen phase of the hair cycle. For this reason the hair passes earlier into the telogen phase and falls out. Gradually, over succeeding cycles terminal hair converts into thinner and shorter vellus hair (i.e. the retrograde phase of the cycle) and the hair follicle becomes minute. The density of the androgenic receptors in the hair follicles varies according to location and this is genetically determined. Age factors too play an important role in AGA, the first manifestation is usually appearing in the third decade. In the late stage, involution of all the structures in corium becomes apparent; the terminal hairs turn into subtle, vellus hairs, which are located higher in the dermis.
2. Low -level laser (light) therapy. In 1967 a few years after the first working laser was invented, Endre Mester in Semmelweis University, Budapest, Hungary decided to test if laser radiation might cause cancer in mice . He shaved the hair off their backs, divided them into two groups and gave a laser treatment with a low powered ruby laser (694-nm) to one group. They did not get cancer and to his surprise the hair on the treated group grew back more quickly than the untreated group. This was the first demonstration of "laser biostimulation". Since then, medical treatment with coherent-light sources (lasers) or noncoherent light (light-emitting diodes, LEDs) has passed through its childhood and adolescence. Currently, low-level laser (or light) therapy (LLLT), also known as “cold laser”, “soft laser”, “biostimulation” or “photobiomodulation” — is considered part of light therapy as well as part of physical therapy. In fact, light therapy is one of the oldest therapeutic methods used by humans (historically as solar therapy by Egyptians, later as UV therapy for which Nils Finsen won the Nobel prize in 1904 ). The use of lasers and LEDs as light sources was the next step in the technological development of light therapy, which is now applied to many thousands of people worldwide each day. In LLLT the question is no longer whether light has biological effects but rather how energy from therapeutic lasers and LEDs works at the cellular and organism levels and what the optimal light parameters are for different uses of these light sources. One important point that has been demonstrated by multiple studies in cell culture, animal models  and in clinical studies is the concept of a biphasic dose response with the total delivered light energy density (fluence). The reason why the technique is termed LOW-level is that there exists an optimal dose of light for any
particular application, and dose lower than this optimum value, or more significantly, larger than the optimum value will have a diminished therapeutic outcome, or for high doses of light a negative outcome may result.
3. Biological basis for LLLT. The first law of photobiology states that for low power visible light to have any effect on a living biological system, the photons must be absorbed by electronic absorption bands belonging to some molecular chromophore or photoacceptor . One approach to finding the identity of this chromophore is to carry out action spectra. This is a graph representing biological photoresponse as a function of wavelength, wave number, frequency, or photon energy and should resemble the absorption spectrum of the photoacceptor molecule. The existence of a structured action spectrum is strong evidence that the phenomenon under study is a photobiological one (i.e., cellular photoacceptors and signaling pathways exist). The second important consideration involves the optical properties of tissue. Both the absorption and scattering of light in tissue are wavelength dependent (both much higher in the blue region of the spectrum than the red) and the principle tissue chromophores (hemoglobin and melanin) have high absorption bands at wavelengths shorter than 600-nm. Water begins to absorb significantly at wavelengths greater than 1150-nm. For these reasons there is a so-called “optical window” in tissue covering the red and near-infrared wavelengths, where the effective tissue penetration of light is maximized (Figure 1). Therefore although blue, green and yellow light may have significant effects on cells growing in optically transparent culture medium, the use of LLLT in animals and patients almost exclusively involves red and near-infrared light (600-950-nm). It was suggested in 1989 that the mechanism of LLLT at the cellular level was based on the absorption of monochromatic visible and NIR radiation by components of the cellular respiratory chain . Respiration occurs in subcellular organelles called mitochondria. The inner mitochondrial membrane contains 5 complexes of integral
400 600 800 1000 1200 1400 1600 1800 2000
water Hb HbO2 Melanin
Figure 1. The optical window in tissue between 600 and 1200 nm where absorption of light by tissue chromophores is minimized
membrane proteins: NADH dehydrogenase (Complex I), succinate dehydrogenase (Complex II), cytochrome c reductase (Complex III), cytochrome c oxidase (Complex IV), ATP synthase (Complex V) and two freely-diffusible molecules ubiquinone and cytochrome c that shuttle electrons from one complex to the next. The respiratory chain accomplishes the stepwise transfer of electrons from NADH and FADH2 (produced in the citric acid or Krebs cycle) to oxygen molecules to form (with the aid of protons) water molecules harnessing the energy released by this transfer to the pumping of protons (H+) from the matrix to the intermembrane space. The gradient of protons formed across the inner membrane by this process of active transport forms a miniature battery. The protons can flow back down this gradient, reentering the matrix, only
Figure 2. Action spectra for (A) DNA synthesis, (B) RNA synthesis, (C) cellplastic adhesion, and (D) absorption spectra of dried cell layer. HeLa (human cervical carcinoma) cells were used.
4. Experiments in isolated mitochondria Since the respiratory chain and cytochrome c oxidase are located in mitochondria, several groups have tested the effect of LLLT on preparations of isolated mitochondria. The most popular system to study is the effects of HeNe laser illumination of mitochondria isolated from rat liver. Increased proton electrochemical potential and ATP synthesis was found . Increased RNA and protein synthesis was demonstrated after 5 J/cm2 . Pastore et al  found increased activity of cytochrome c oxidase and an increase in polarographically measured oxygen uptake after 2 J/cm2 of HeNe. A major
stimulation in the proton pumping activity, about 55% increase of <--H+/e- ratio was found in illuminated mitochondria. Yu et al  used 660 nm laser at a power density of 10 mW/cm2 and showed increased oxygen consumption (0.6 J/cm2 and 1.2 J/cm2), increased phosphate potential, and energy charge (1.8 J/cm2 and 2.4 J/cm2) and enhanced activities of NADH: ubiquinone oxidoreductase, ubiquinol: ferricytochrome C oxidoreductase and ferrocytochrome C: oxygen oxidoreductase (0.6 J/cm2, 1.2 J/cm2, 2.4 J/cm2 and 4.8 J/cm2).
5. Cell types responding to LLLT. There is evidence that multiple mammalian and microbial cell types can respond to LLLT. Much of Karu’s work has used Escherichia coli (a Gram-negative aerobic bacterium)  and HeLa cells , a human cervical carcinoma cell line. However for the clinical applications of LLLT to be validated it is much more important to study the effects of LLLT on non-malignant cell types likely to be usefully stimulated to remediate some disease or injury. For wound healing type studies, these cells are likely to be endothelial cells , fibroblasts , keratinocytes  and possibly some classes of leukocytes such as macrophages  and neutrophils . For pain relief and nerve regrowth studies these cells will be neurons [30-32] and glial cells . For antiinflammatory and anti-edema applications the cell types will be macrophages , mast-cells , neutrophils , lymphocytes  etc. There is literature evidence for in vitro LLLT effects for most of these cell types. 6. Animal studies. It is probable that applications of LLLT in animal models will be more effective if carried out on models that have some intrinsic disease state. Although there have been several reports that processes such as wound healing are accelerated by LLLT in normal rodents [3, 37], an alternative approach is to inhibit healing by inducing some specific disease state. This has been done in the case of diabetes, a disease known to significantly depress wound healing in patients. LLLT significantly improves wound healing in both diabetic rats [38, 39] and diabetic mice [40, 41]. LLLT was also effective in X-radiation impaired wound healing in mice . Another report  found a greater effect of LLLT in stimulating wound healing in malnourished compared to normally fed rats. Other animal models employed to study LLLT effects in tissue repair include bone fracture healing in rats , regenerating rat facial and sciatic nerves after crush injury or transection ,
7. Clinical applications for LLLT. LLLT is used by physical therapists (to treat a wide variety of acute and chronic musculoskeletal aches and pains), by dentists (to treat inflamed oral tissues and to heal diverse ulcerations), by dermatologists (to treat edema, non-healing ulcers, burns, and dermatitis), by rheumatologists (to relieve pain and treat chronic inflammations and autoimmune diseases), and by other specialists, as well as general practitioners. Laser therapy is also widely used in veterinary medicine (especially in racehorse-training centers) and in sports-medicine and rehabilitation clinics (to reduce swelling and hematoma, relieve pain, improve mobility, and treat acute soft-tissue injuries). Lasers and LEDs are applied directly to the respective areas (e.g., wounds, sites of injuries) or
to various points on the body (acupuncture points, muscle-trigger points). The methods for delivering the therapeutic light are diverse. The field is characterized by a variety of methodologies and uses of various light sources (lasers, LEDs) with different parameters (wavelength, output power, continuous-wave or pulsed operation modes, pulse parameters, polarization state etc). In 2002 MicroLight Corp received 510K FDA clearance for the ML 830-nm diode laser for treatment of carpal tunnel syndrome. There were several controlled trials reporting significant improvement in pain and some improvement in objective outcome measures [46-48]. Since then several light sources have been approved as equivalent to an infra-red heating lamp for treating a wide-range of musculoskeletal disorders with no supporting clinical studies.
8. Light sources for LLLT. There exists a bewildering variety of light sources employed as therapeutic devices, possible wavelengths they can emit, and maximal output power used in LLLT. For many years HeNe lasers (632.8-nm) were the preferred light source. Light emitting semiconductor diodes (GaAlAs, AlGaInP, InGaAsP etc) are used in both diode lasers and LEDs; the difference is whether the device contains the resonator (as the laser does) or not (LED). These diodes are available in a wide range of wavelengths from 630-nm to 980-nm. In recent years, longer wavelengths (~800 to 900 nm) and higher output powers (to 100 mW) have been preferred in therapeutic devices. One of the most topical and widely discussed issues in the low-power-laser-therapy clinical community is whether the coherence and polarization of laser radiation have additional benefits as compared with monochromatic light from a conventional light source or LED with the same wavelength and intensity. One theory that could explain the extra positive benefit that many practitioners insist is provided by laser over non-coherent light, is the action of laser speckle. Speckle is more pronounced in long-coherence length lasers such as HeNe. Laser speckle provides a rapidly alternating pattern of varying energy density with a spatial dimension of approximately 1 micron. The theory proposes that this dimension is on the same order of magnitude as the size of mitochondria inside the cell, and could explain the extra stimulation provided by a laser. There does not seem to be any scientific explanation for claims that pulse structure (pulse length and repetition rate) and/or polarization state of the light are important or even crucial variables in LLLT.
9. LLLT for hair regrowth. Since the first pioneering publication of Mester  reported stimulation of hair growth in mice, there have been virtually no follow-up studies on LLLT stimulation for hair growth in animal models. Mester’s study involved delivering 1 J of pulsed light (1 millisecond pulse duration) into a 1 cm2 spot from a ruby laser at 694-nm to the depilated abdominal area of black C57 and white Balb/c mice every week for up to 11 weeks. Before each successive treatment the skin was again depilated. Increased hair growth in the irradiated spot growth was observed in all black animals between the 5th and 7th treatment. This reaction continued to the 9th treatment and it was characteristic of the hair growth intensity that in places that were completely bare at the time of the respective irradiation, hair growth as dense as on other body parts was observed only 4
– 6 days after the irradiation. On the other hand, it was found after the 9th irradiation that hair growth stopped in the irradiated locations only. Instead, a peripheral, ringshaped hair growth was observed around the irradiated area. This ring-shaped hair growth first appeared in the animal on which the central growth stimulation was first observed. The peripheral growth appeared in all treated black mice between the 7th and 9th irradiation with the intensity varying from mouse to mouse. In white mice no effect on hair growth was detected up to the 8th irradiation. The central growth described for black mice only began to form after the 8th irradiation. Further irradiation caused the hair growth just described in some of the mice, but the peripheral hair growth characteristic of the 2nd phase was already appearing in some as well. The hair growth of the control animals developed as follows: The depilated skin grew hair slowly and diffusely. However, on half of the control animals (both among black and white mice), no further hair growth whatsoever was observed. At the same time, a diffuse hair growth appeared on some animals, but in other animals an uncharacteristic, sometimes diagonal strip appeared. Despite the fact that LLLT devices are widely marketed and used for hair regrowth, there have been only a few literature reports containing some observations of LLLT-induced hair growth in patients, and amelioration or treatment of any type of alopecia. A Japanese group reported  on the use of Super Lizer (a linear polarized light source providing 1.8W of 600 – 1600-nm light) to treat alopecia areata. Threeminute sessions every one or two weeks produced significant hair growth compared to non-treated lesions in 47% of patients. A Spanish group has reported [50, 51] on the use of HeNe laser for both alopecia androgenic and areata. A report from Finland  compared three different light sources used for male-pattern baldness (HeNe laser, InGaAl diode laser at 670-nm and non-coherent 635-nm LED and measured blood flow in the scalp. Recent work has uncovered some biological mechanisms involved in the regulation of hair growth that could be good candidates to explain the stimulating effects of LLLT. Peters et al  found that nerve growth factor (NGF) promotes proliferation via its high affinity receptor (TrkA). and identified NGF and p75 as important hair growth terminators. By rtPCR we found, that NGF/proNGF mRNA levels peak during early anagen in murine back skin while NGF/proNGF protein levels peak during catagen, indicating high turnover in early anagen and protein accumulation in catagen. By immunohistochemistry, NGF and TrkA were found in the proliferating compartments of the epidermis and hair follicle throughout the cycle. Commercial 7S NGF, which contains both NGF and proNGF, promotes anagen development in organ-cultured early anagen mouse skin, while it promotes catagen development in late anagen skin. Therefore the data suggest an anagen-promoting/-supporting role for NGF/TrkA. Another report from this group  studied the expression and function of p75 neurotrophin receptor (p75NTR), which is implicated in apoptosis control in spontaneous catagen development in murine skin. They found that p75NTR alone was strongly expressed in TUNEL+/Bcl2- keratinocytes of the regressing outer root sheath, but both p75NTR and TrkB and/or TrkC were expressed by the nonregressing TUNEL/Bcl2+ secondary hair germ keratinocytes. There was significant catagen retardation in p75NTR knockout mice as compared to wild-type controls. Instead, transgenic miceoverexpressing NGF (promoter: K14) showed substantial acceleration of catagen.
Schwartz et al  reported in 2002 that helium/neon laser irradiation (3J/cm2) augmented the level of NGF mRNA fivefold and increased NGF release to the medium of myotubes cultured in vitro. This correlated with a transient elevation of intracellular calcium in the myotubes. Yu and coworkers found a significant increase in nerve growth factor release from cultured human keratinocytes. . Therefore it is postulated that LLLT may influence hair regrowth via the NGF/ p75NTR signaling system. Zcharia and colleagues  identified the endoglycosidase, heparanase, as an Important regulator of murine hair growth. Degradation of the extracellular matrix barrier formed by heparan sulfate by heparanase enables cell movement through extracellular barriers and releases growth factors from extracellular matrix depots, making them bioavailable. This allows follicular stem cell progeny migration and reconstitution of the lower part of the follicle, which is a prerequisite for hair shaft formation. Heparanase contributed to the ability of the bulge-derived keratinocytes to migrate through the extracellular matrix barrier in vitro. In heparanase-overexpressing transgenic mice, increased levels of heparanase enhanced active hair growth and enabled faster hair recovery after chemotherapy-induced alopecia. Thymosin beta4 (TB4) is a 43-amino acid polypeptide that is an important mediator of cell migration and differentiation, also promotes angiogenesis and wound healing . Philp et al  reported that TB4 stimulated hair growth in normal rats and mice. A specific subset of hair follicular keratinocytes in mouse skin expressed TB4 in a highly coordinated manner during the hair growth cycle. These keratinocytes originated in the hair follicle bulge region, a niche for skin stem cells. Rat vibrissa follicle clonogenic keratinocytes, closely related, if not identical, to the bulge-residing stem cells, were isolated and their migration and differentiation increased in the presence of nanomolar concentrations of TB4. Expression and secretion of the extracellular matrixdegrading enzyme matrix metalloproteinase-2 were increased by TB4. Thus, TB4 accelerated hair growth, in part, due to its effect on critical events in the active phase of the hair follicle cycle, including promoting the migration of stem cells and their immediate progeny to the base of the follicle, differentiation, and extracellular matrix remodeling. A recent report  identified the transforming growth factor-beta family member activin is a potent regulator of skin morphogenesis, repair and hair growth. Mice overexpressing the secreted activin antagonist follistatin, however, have the reduced hair growth. Mice expressing a dominant-negative activin receptor IB mutant (dnActRIB) in keratinocytes had unaltered architecture of adult skin, but delays were observed in postnatal pelage hair follicle morphogenesis and in the first catagen-telogen transformation of hair follicles. As yet there are no reports of LLLT affecting heparanase, TB4, or activin expression levels in tissue culture or in mouse skin, but these molecules are good candidates for further study to explain the hair growth-induction by LLLT.
References  E. Mester, B. Szende and P. Gartner, The effect of laser beams on the growth of hair in mice, Radiobiol Radiother (Berl) 9 (1968) 621-6.  R. Roelandts, The history of phototherapy: something new under the sun?, J Am Acad Dermatol 46 (2002) 926-30.
 J.S. Kana, G. Hutschenreiter, D. Haina and W. Waidelich, Effect of low-power density laser radiation on healing of open skin wounds in rats, Arch Surg 116 (1981) 293-6.  J.C. Sutherland, Biological effects of polychromatic light, Photochem Photobiol 76 (2002) 164-70.  T. Karu, Laser biostimulation: a photobiological phenomenon, J Photochem Photobiol B 3 (1989) 638-40.  T.I. Karu and N.I. Afanas' eva, Cytochrome c oxidase as the primary photoacceptor upon laser exposure of cultured cells to visible and near IR-range light, Dokl Akad Nauk 342 (1995) 693-5.  R.A. Capaldi, F. Malatesta and V.M. Darley-Usmar, Structure of cytochrome c oxidase, Biochim Biophys Acta 726 (1983) 135-48.  I. Szundi, G.L. Liao and O. Einarsdottir, Near-infrared time-resolved optical absorption studies of the reaction of fully reduced cytochrome c oxidase with dioxygen, Biochemistry 40 (2001) 2332-9.  T.I. Karu and S.F. Kolyakov, Exact action spectra for cellular responses relevant to phototherapy, Photomed Laser Surg 23 (2005) 355-61.  W. Yu, J.O. Naim, M. McGowan, K. Ippolito and R.J. Lanzafame, Photomodulation of oxidative metabolism and electron chain enzymes in rat liver mitochondria, Photochem Photobiol 66 (1997) 866-71.  S. Passarella, He-Ne laser irradiation of isolated mitochondria, J Photochem Photobiol B 3 (1989) 642-3.  H. Friedmann, R. Lubart, I. Laulicht and S. Rochkind, A possible explanation of laser-induced stimulation and damage of cell cultures, J Photochem Photobiol B 11 (1991) 87-91.  M. Eichler, R. Lavi, A. Shainberg and R. Lubart, Flavins are source of visiblelight-induced free radical formation in cells, Lasers Surg Med 37 (2005) 314-9.  R. Lubart, M. Eichler, R. Lavi, H. Friedman and A. Shainberg, Low-energy laser irradiation promotes cellular redox activity, Photomed Laser Surg 23 (2005) 3-9.  R. Duan, T.C. Liu, Y. Li, H. Guo and L.B. Yao, Signal transduction pathways involved in low intensity He-Ne laser-induced respiratory burst in bovine neutrophils: a potential mechanism of low intensity laser biostimulation, Lasers Surg Med 29 (2001) 174-8.  T.I. Karu, L.V. Pyatibrat and N.I. Afanasyeva, Cellular effects of low power laser therapy can be mediated by nitric oxide, Lasers Surg Med 36 (2005) 307-14.  D. Gius, A. Botero, S. Shah and H.A. Curry, Intracellular oxidation/reduction status in the regulation of transcription factors NF-kappaB and AP-1, Toxicol Lett 106 (1999) 93-106.  Y. Sun and L.W. Oberley, Redox regulation of transcriptional activators, Free Radic Biol Med 21 (1996) 335-48.  H. Nakamura, K. Nakamura and J. Yodoi, Redox regulation of cellular activation, Annu Rev Immunol 15 (1997) 351-69.  S. Passarella, E. Casamassima, S. Molinari, D. Pastore, E. Quagliariello, I.M. Catalano and A. Cingolani, Increase of proton electrochemical potential and ATP synthesis in rat liver mitochondria irradiated in vitro by helium-neon laser, FEBS Lett 175 (1984) 95-9.
 M. Greco, G. Guida, E. Perlino, E. Marra and E. Quagliariello, Increase in RNA and protein synthesis by mitochondria irradiated with helium-neon laser, Biochem Biophys Res Commun 163 (1989) 1428-34.  D. Pastore, M. Greco, V.A. Petragallo and S. Passarella, Increase in <--H+/e- ratio of the cytochrome c oxidase reaction in mitochondria irradiated with heliumneon laser, Biochem Mol Biol Int 34 (1994) 817-26.  O. Tiphlova and T. Karu, Action of low-intensity laser radiation on Escherichia coli, Crit Rev Biomed Eng 18 (1991) 387-412.  T.I. Karu, L.V. Pyatibrat, G.S. Kalendo and R.O. Esenaliev, Effects of monochromatic low-intensity light and laser irradiation on adhesion of HeLa cells in vitro, Lasers Surg Med 18 (1996) 171-7.  P. Moore, T.D. Ridgway, R.G. Higbee, E.W. Howard and M.D. Lucroy, Effect of wavelength on low-intensity laser irradiation-stimulated cell proliferation in vitro, Lasers Surg Med 36 (2005) 8-12.  D. Hawkins and H. Abrahamse, Biological effects of helium-neon laser irradiation on normal and wounded human skin fibroblasts, Photomed Laser Surg 23 (2005) 251-9.  H.S. Yu, C.S. Wu, C.L. Yu, Y.H. Kao and M.H. Chiou, Helium-neon laser irradiation stimulates migration and proliferation in melanocytes and induces repigmentation in segmental-type vitiligo, J Invest Dermatol 120 (2003) 56-64.  S. Young, P. Bolton, M. Dyson, W. Harvey and C. Diamantopoulos, Macrophage responsiveness to light therapy, Lasers Surg Med 9 (1989) 497-505.  Y. Fujimaki, T. Shimoyama, Q. Liu, T. Umeda, S. Nakaji and K. Sugawara, Lowlevel laser irradiation attenuates production of reactive oxygen species by human neutrophils, J Clin Laser Med Surg 21 (2003) 165-70.  Y.S. Chen, S.F. Hsu, C.W. Chiu, J.G. Lin, C.T. Chen and C.H. Yao, Effect of lowpower pulsed laser on peripheral nerve regeneration in rats, Microsurgery 25 (2005) 83-9.  M. Miloro, L.E. Halkias, S. Mallery, S. Travers and R.G. Rashid, Low-level laser effect on neural regeneration in Gore-Tex tubes, Oral Surg Oral Med Oral Pathol Oral Radiol Endod 93 (2002) 27-34.  P. Balaban, R. Esenaliev, T. Karu, E. Kutomkina, V. Letokhov, A. Oraevsky and N. Ovcharenko, He-Ne laser irradiation of single identified neurons, Lasers Surg Med 12 (1992) 329-37.  K.R. Byrnes, R.W. Waynant, I.K. Ilev, X. Wu, L. Barna, K. Smith, R. Heckert, H. Gerst and J.J. Anders, Light promotes regeneration and functional recovery and alters the immune response after spinal cord injury, Lasers Surg Med 36 (2005) 171-85.  S.O. el Sayed and M. Dyson, Effect of laser pulse repetition rate and pulse duration on mast cell number and degranulation, Lasers Surg Med 19 (1996) 433-7.  R.A. Lopes-Martins, R. Albertini, P.S. Martins, J.M. Bjordal and H.C. Faria Neto, Spontaneous effects of low-level laser therapy (650 nm) in acute inflammatory mouse pleurisy induced by Carrageenan, Photomed Laser Surg 23 (2005) 37781.
 A.D. Agaiby, L.R. Ghali, R. Wilson and M. Dyson, Laser modulation of angiogenic factor production by T-lymphocytes, Lasers Surg Med 26 (2000) 35763.  D. Bisht, S.C. Gupta, V. Misra, V.P. Mital and P. Sharma, Effect of low intensity laser radiation on healing of open skin wounds in rats, Indian J Med Res 100 (1994) 43-6.  K.R. Byrnes, L. Barna, V.M. Chenault, R.W. Waynant, I.K. Ilev, L. Longo, C. Miracco, B. Johnson and J.J. Anders, Photobiomodulation improves cutaneous wound healing in an animal model of type II diabetes, Photomed Laser Surg 22 (2004) 281-90.  G.A. Maiya, P. Kumar and L. Rao, Effect of low intensity helium-neon (He-Ne) laser irradiation on diabetic wound healing dynamics, Photomed Laser Surg 23 (2005) 187-90.  I. Stadler, R.J. Lanzafame, R. Evans, V. Narayan, B. Dailey, N. Buehner and J.O. Naim, 830-nm irradiation increases the wound tensile strength in a diabetic murine model, Lasers Surg Med 28 (2001) 220-6.  W. Yu, J.O. Naim and R.J. Lanzafame, Effects of photostimulation on wound healing in diabetic mice, Lasers Surg Med 20 (1997) 56-63.  A.S. Lowe, M.D. Walker, M. O' Byrne, G.D. Baxter and D.G. Hirst, Effect of low intensity monochromatic light therapy (890 nm) on a radiation-impaired, woundhealing model in murine skin, Lasers Surg Med 23 (1998) 291-8.  A.L. Pinheiro, G.C. Meireles, A.L. de Barros Vieira, D. Almeida, C.M. Carvalho and J.N. dos Santos, Phototherapy improves healing of cutaneous wounds in nourished and undernourished Wistar rats, Braz Dent J 15 Spec No (2004) SI218.  E.J. Luger, S. Rochkind, Y. Wollman, G. Kogan and S. Dekel, Effect of lowpower laser irradiation on the mechanical properties of bone fracture healing in rats, Lasers Surg Med 22 (1998) 97-102.  J.J. Anders, S. Geuna and S. Rochkind, Phototherapy promotes regeneration and functional recovery of injured peripheral nerve, Neurol Res 26 (2004) 233-9.  K. Branco and M.A. Naeser, Carpal tunnel syndrome: clinical outcome after lowlevel laser acupuncture, microamps transcutaneous electrical nerve stimulation, and other alternative therapies--an open protocol study, J Altern Complement Med 5 (1999) 5-26.  J. Irvine, S.L. Chong, N. Amirjani and K.M. Chan, Double-blind randomized controlled trial of low-level laser therapy in carpal tunnel syndrome, Muscle Nerve 30 (2004) 182-7.  M.I. Weintraub, Noninvasive laser neurolysis in carpal tunnel syndrome, Muscle Nerve 20 (1997) 1029-31.  M. Yamazaki, Y. Miura, R. Tsuboi and H. Ogawa, Linear polarized infrared irradiation using Super Lizer is an effective treatment for multiple-type alopecia areata, Int J Dermatol 42 (2003) 738-40.  J.L. Cisneros-Vela and M. Marti-Roses, Estudio compartivo del tratamiento de las alopecias androgenicas y alopecias totales y universales con laser, PUVA y Minoxadil, Invest Clin Laser 4 (1987) 12-16.
 M. Trelles, E. Mayayo and J.L. Cisneros, Tratemento de la alopecia areata con laser He/Ne, Invest Clin Laser 1 (1984) 15-17.  P.J. Pontinen, T. Aaltokallio and P.J. Kolari, Compative effects of exposure to different light sources (heNe laser, InGaAl diode laser, a specific type of noncoherent LED) on skin blood flow of the head, Acupuncture Electro-Ther Res Int 21 (1996) 105-118.  E.M. Peters, S. Hendrix, G. Golz, B.F. Klapp, P.C. Arck and R. Paus, Nerve Growth Factor and Its Precursor Differentially Regulate Hair Cycle Progression in Mice, J Histochem Cytochem (2005).  V.A. Botchkarev, N.V. Botchkareva, K.M. Albers, L.H. Chen, P. Welker and R. Paus, A role for p75 neurotrophin receptor in the control of apoptosis-driven hair follicle regression, Faseb J 14 (2000) 1931-42.  F. Schwartz, C. Brodie, E. Appel, G. Kazimirsky and A. Shainberg, Effect of helium/neon laser irradiation on nerve growth factor synthesis and secretion in skeletal muscle cultures, J Photochem Photobiol B 66 (2002) 195-200.  E. Zcharia, D. Philp, E. Edovitsky, H. Aingorn, S. Metzger, H.K. Kleinman, I. Vlodavsky and M. Elkin, Heparanase regulates murine hair growth, Am J Pathol 166 (2005) 999-1008.  A.L. Goldstein, E. Hannappel and H.K. Kleinman, Thymosin beta4: actinsequestering protein moonlights to repair injured tissues, Trends Mol Med 11 (2005) 421-9.  D. Philp, M. Nguyen, B. Scheremeta, S. St-Surin, A.M. Villa, A. Orgel, H.K. Kleinman and M. Elkin, Thymosin beta4 increases hair growth by activation of hair follicle stem cells, Faseb J 18 (2004) 385-7.  C. Bamberger, A. Scharer, M. Antsiferova, B. Tychsen, S. Pankow, M. Muller, T. Rulicke, R. Paus and S. Werner, Activin controls skin morphogenesis and wound repair predominantly via stromal cells and in a concentration-dependent manner via keratinocytes, Am J Pathol 167 (2005) 733-47.